Search
Adaptive Biotechnologies Corp
ADPTAdd to Watchlist
17.530USD
+0.750+4.47%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
2.80BMarket Cap
LossP/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
MRD revenue
212.33M
76.66%
Immune meidicine revenue
64.64M
23.34%
Relevant data have not been disclosed by the company yet.
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
MRD revenue
212.33M
76.66%
Immune meidicine revenue
64.64M
23.34%
